Jinan Jiage biological technology co., LTD(expird)
Free supplier
- Free
supplier - 8th
years
Free supplier
Business Type:Trading Company
Product Certification&
Enterprise Certification
Country: 
China (Mainland)
Business Type:Trading Company
CAS NO.218949-48-5
Enterprise Standard(10-100)GramEnterprise Standard(101-1000)Gram
99% White Lyophilized Peptide Powder Tesamorelin For Muscle Building
|
CAS |
218949-48-5 |
|
MF |
C151H228N40O47 |
|
MW |
3355.67 |
|
Purity |
99% |
|
Appearance |
White powder |
|
Certification |
GMP, ISO 9001, USP |
|
Standard |
Enterprise standard |
|
Single Impurity (HPLC) |
0.5%max |
|
Amino Acid Composition |
± 10% of theoretical |
|
Mass Balance |
95.0~105.0% |
|
Usage |
It stimulates the production of growth hormones by binding to receptors on anterior pituitary cells |
|
Packing |
Discreet packing ways as your requirement, 100% go through |
|
Storage |
Store in cool and dry area and keep away from direct sunlight |
Description:
Tesamorelin, (formerly known as TH9507), is a type of peptide called a growth hormone-releasing factor (GHRF). GHRF causes growth hormone to be created and spread in the body, which helps increase metabolism, reduce belly fat, improve body shape, and use of energy.
Tesamorelin (formerly known as TH9507) is a synthetic growth hormone-releasing factor that stimulates the pituitary gland in the brain to secrete growth hormone; this indirect approach appears to maintain more stable, natural levels, like CJC-1295 DAC,. Clinical trials have shown that tesamorelin significantly reduces abdominal fat with fewer side effects than human growth hormone itself, although abdominal fat may return after the Tesamorlein is discontinued (depending upon the individual). Tesamorelin has been shown to reduce lipodystrophy in HIV-infected individuals as well as similarly reducing abdominal fat in NON-HIV-Infected individuals.
This medication is a synthetic GHRF. It stimulates the production of growth hormones by binding to receptors on anterior pituitary cells. These growth hormones affect metabolism and body shape. Tesamorelin targets fat accumulation in the abdominal area specifically. As this drug releases growth hormones, patients with active cancer should not take it.
The recommended dosage of tesamorelin is one daily 2-milligram subcutaneous injection. The medication is usually injected into the abdomen. The injection site should be rotated, avoiding scars, the navel, and bruises.
Prior to FDA approval, clinical studies were conducted on patients with HIV who had some fat accumulation and whose antiviral therapy was stable. Three studies of 816 patients showed that a daily treatment reduced abdominal fat after 26 weeks. Most patients experienced a reduction of approximately 18 percent. Abdominal fat began to accumulate again once the patients stopped treatment.
Application:
1. Triptorelin raises testosterone levels by causing constant stimulation of the pituitary, it decreases pituitary secretion of gonadotropins luteinizing hormone (LH) and follicle stimulating hormone (FSH).
2. Like other GnRH agonists, triptorelin may be used in the treatment of hormone-responsive cancers such as prostate cancer or breast cancer, precocious puberty,estrogen-dependent conditions (such as endometriosis or uterine fibroids), and in assisted reproductin.